Cravath Publishes Winter 2026 Issue of Alumni Journal
June 23, 2026
On June 23, 2026, Westinghouse Electric Corporation (“Westinghouse”) announced its intention to partner with the U.S. Department of Energy (“DOE”) Office of Energy Dominance Financing (“EDF”) under the American Nuclear Supply Chain Loans program. The program will enable investment in nuclear supply chains and accelerate deployment of new nuclear generation at scale in the United States. EDF has announced a conditional commitment (subject to Westinghouse, its owners and its partners satisfying certain conditions) of $17.5 billion in obligated funds to finance the purchase of long‑lead time items (“LLI”) for up to 10 Westinghouse AP1000® units, the only fully designed and licensed advanced commercial reactor operating in the United States today. Westinghouse will partner with up to five eligible utilities or energy companies to procure LLI for projects with two reactors each and has signed letters of intent with seven potential partners with identified sites. Cravath is representing Westinghouse in connection with the transaction.
The Cravath team is led by partners Richard Hall, Andrew C. Compton and Adam M. Sanchez and includes of counsels Will Kim and April M. Kent and associates Maurice Temming, Helen Catherine Darby, Rebecca Ryan, Blake J. Sloane and J. Eunice Sohn and foreign associate attorney Mylla Mattar on corporate matters; partners Lauren Angelilli and Christopher K. Fargo and associates Frederick Schemel and Jonathan Jiang on tax matters; and partner Sasha Rosenthal-Larrea on intellectual property matters. Jack Weinert also worked on intellectual property matters. Summer associates Jeremy A. Ashe, Caitlyn Victoria Lee and Brooke Schwind also worked on corporate matters.
Deals & Cases
June 16, 2026
On June 16, 2026, Olin Corporation and Huntsman Corporation announced that they have entered into a definitive agreement to combine in an all-stock merger of equals to create a $12+ billion North American chemicals leader. Under the terms of the agreement, Huntsman shareholders will receive 0.5476 shares in Olin for every one share of Huntsman. Upon completion of the transaction, Olin shareholders will own approximately 54.5% and Huntsman shareholders will own approximately 45.5% of the combined company, which will be renamed OlinHuntsman Corporation. Upon closing of the transaction, current Olin President and Chief Executive Officer, Ken Lane, will serve as Chief Executive Officer of OlinHuntsman. Current Chairman, President and Chief Executive Officer of Huntsman, Peter Huntsman, will serve as non-executive Chairman of OlinHuntsman’s Board of Directors. OlinHuntsman’s Board of Directors will consist of ten members, with equal representation from Olin and Huntsman. The transaction is expected to close in the first half of 2027, subject to the satisfaction of customary closing conditions, including receipt of required regulatory approvals and the approval of Olin’s shareholders and Huntsman’s shareholders. Cravath is representing Olin Corporation in connection with the transaction.
Deals & Cases
May 08, 2026
On May 8, 2026, Array Digital Infrastructure, Inc. (“Array”) confirmed that its board of directors has received a non‑binding proposal from Telephone and Data Systems, Inc. (“TDS”) to acquire all of the outstanding common shares of Array not currently owned by TDS. Currently, TDS owns approximately 81.9% of the outstanding capital stock of and 95.9% of the voting interests in Array. The proposal is conditioned on, among other things, the recommendation of a special committee of disinterested and independent directors of Array and the approval by a majority of the votes cast by disinterested stockholders. Cravath is representing the special committee in connection with the proposal.
Deals & Cases
May 01, 2026
On April 27, 2026, Integris, a national leader in managed AI and IT services backed by OMERS Private Equity, announced its intent, subject to regulatory approval, to acquire First Focus, the largest managed service provider serving small and midsize businesses in Australia, New Zealand and the Philippines. Cravath is representing Integris as U.S. counsel in connection with the transaction.
Deals & Cases
April 27, 2026
On April 27, 2026, Thermo Fisher Scientific Inc. (“Thermo Fisher”), the world leader in serving science, announced that it has signed a definitive agreement to sell its microbiology business, which provides antimicrobial susceptibility testing and culture media solutions for clinical, pharmaceutical and food safety testing, to Astorg, a leading pan‑European private equity firm, for consideration of approximately $1.075 billion, consisting of cash and a $50 million seller note. Cravath is representing Thermo Fisher in connection with the transaction.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2026 Cravath, Swaine & Moore LLP.